+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Opana"

Opana ER - API Insight, 2022 - Product Thumbnail Image

Opana ER - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Opana ER- Drug Insight, 2019 - Product Thumbnail Image

Opana ER- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Opana is an analgesic drug used to treat moderate to severe pain. It is a brand name for oxymorphone, an opioid agonist that works by binding to opioid receptors in the brain and spinal cord. Opana is available in both immediate-release and extended-release formulations, and is typically prescribed for chronic pain management. It is also used to treat breakthrough pain, a type of pain that occurs despite the use of other pain medications. Opana is a Schedule II controlled substance, meaning it has a high potential for abuse and addiction. As such, it is only available by prescription and is subject to strict regulations. Common side effects of Opana include nausea, constipation, dizziness, and drowsiness. The Opana market is composed of a variety of companies that manufacture and distribute the drug. These include Endo Pharmaceuticals, Purdue Pharma, and Mallinckrodt Pharmaceuticals. Other companies involved in the market include Teva Pharmaceuticals, Mylan Pharmaceuticals, and Actavis Pharma. Show Less Read more